Implementation of the Global Product Strategy in North America
Clariant has implemented an assessment process for the purpose of identifying the chemicals in our product portfolio that require additional risk characterization. The results of the risk characterization are used to determine whether additional or enhanced risk management measures are required. These measures are intended to ensure that products containing these chemicals are safely used and handled throughout the value chain.
Several criteria are used to determine which chemicals should receive the highest priority for assessment. These criteria include:
• Inherent chemical and physical hazards
• Toxicity to human health and the environment
• Production volume
• End use
• Potential for exposure
• Business relevance
• National and international regulatory focus
• Public perception
Other criteria can be used when chemical-specific information is or becomes available that has relevance to the assessment.
The assessments are documented in our Global Product Strategy summary reports, which can be found at here.This process conforms to the American Chemistry Council Responsible Care® Product Safety Code and the International Council of Chemical Associations’ Global Product Strategy.